EWTX

SEC filing EWTX Sells Muscular Dystrophy Business to Servier for $1.55B Upfront, Up to $2.65B Total Deal Value

1d ago

News Why Edgewise Therapeutics Stock Is Up 50% on Thursday

14d ago

News Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?

14d ago

News Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge

14d ago

SEC filing EWTX Reports $12M Q1 Rev, $0.00 EPS, Advances Sevasemten in Becker, EDG-7500 HCM Data Q2, GRAND CANYON Q4

26d ago

Insider trade Sale by Joanne M. Donovan (CMO)

27d ago

Scanner Unusual buy pressure (3.2x avg, 78% up-volume, +21.9% / +7.00 intraday, above VWAP)

28d ago

News Why Edgewise Therapeutics Stock Crushed the Market on Monday

112d ago

News New Jersey's Emerging Medtech Ecosystem Showcased Through Edge Medical Ventures Event at Liberty Science Center

133d ago

News Edgewise Therapeutics, Inc. (EWTX) Outlines Priorities For 2026

137d ago

News Why Edgewise Therapeutics Stock Rocked the Market Today

153d ago

Scanner Unusual volume (z=3.8)

168d ago